RUKLANTHI DE ALWIS

Deputy Director/ Assistant Professor

Duke-NUS Medical School

Singapore

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Ruklanthi De Alwis is the Deputy Director and Assistant Professor at Duke-NUS Medical School in Singapore. Her research focuses on immunology, vaccine efficacy, and pathogen genomic surveillance, with notable contributions to understanding immunogenicity in various vaccine contexts. Recent publications highlight her work on SARS-CoV-2 vaccines, novel vaccine components for Shigella, and advancements in high-throughput serology techniques.

Articles (10)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Lin-Fa Wang

Professor

Duke-NUS Medical School

SINGAPORE

View details

Allen Eng Juh Yeoh

National University of Singapore (NUS)

SINGAPORE

View details

DO THAI HUNG

Visitting Professor

Nagasaki University

JAPAN

View details

Yoong Khean Khoo

Assistant Professor

Duke-NUS Medical School

SINGAPORE

View details

Eng Eong Ooi

Professor

Duke-NUS Medical School

SINGAPORE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

RUKLANTHI DE ALWIS

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Author Correction: Pathogen genomic surveillance status among lower resource settings in Asia

Pathogen genomic surveillance status among lower resource settings in Asia

Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients

Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell–treated patients

Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine

Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals

Early T cell and binding antibody responses are associated with Covid-19 RNA vaccine efficacy onset.

A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.

The identification of novel immunogenic antigens as potential Shigella vaccine components.

Collaborators (5)

Lin-Fa Wang

Allen Eng Juh Yeoh

DO THAI HUNG

Yoong Khean Khoo

Eng Eong Ooi

Make your next move.